| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2000 | EP1011641A1 Use of isoflavonoids in the treatment or prevention of postpartum depression |
| 06/28/2000 | EP1011640A1 Solid pharmaceutical dosage forms in form of a particulate dispersion |
| 06/28/2000 | EP1011638A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 06/28/2000 | EP1011637A1 Modulation of drug loading in multivesicular liposomes |
| 06/28/2000 | EP1011634A1 Preparation of pharmaceutical compositions |
| 06/28/2000 | EP1011632A2 A pharmaceutical composition for treating dysmenorrhea and premature labor |
| 06/28/2000 | EP1011631A1 Antacid composition |
| 06/28/2000 | EP1011610A1 Skin care compositions and use |
| 06/28/2000 | EP1011608A2 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs |
| 06/28/2000 | EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 06/28/2000 | EP1011567A1 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes |
| 06/28/2000 | EP1011346A1 Animal feed containing carboxylic acids |
| 06/28/2000 | EP1011329A1 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels |
| 06/28/2000 | EP1011327A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 06/28/2000 | EP1011320A1 Transplacental delivery of oligonucleotides |
| 06/28/2000 | EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/28/2000 | EP0833899A4 Cis-9,10-octadecenoamidase |
| 06/28/2000 | EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists |
| 06/28/2000 | EP0732918B1 Benzalkonium fluoride injectable solution |
| 06/28/2000 | EP0716601B1 Use of n,s-diacetylcysteine-ethylester (dacee) for the manufacture of a medicament for the treatment of viral diseases |
| 06/28/2000 | EP0715520B1 Use of a suspension based on sucralphate gel as antacid |
| 06/28/2000 | EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy |
| 06/28/2000 | EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 06/28/2000 | CN1258301A Antiviral protease inhibitors |
| 06/28/2000 | CN1258300A Modified benzimidazole nucleosides as antiviral agents |
| 06/28/2000 | CN1258299A Multicyclic erythromycin derivs. |
| 06/28/2000 | CN1258297A Process for producing beta-lactam derivs. |
| 06/28/2000 | CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them |
| 06/28/2000 | CN1258295A Novel form of S-omeprazole |
| 06/28/2000 | CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels |
| 06/28/2000 | CN1258290A Salt |
| 06/28/2000 | CN1258286A Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity |
| 06/28/2000 | CN1258283A Cyclic diamine compounds and medicine contg. same |
| 06/28/2000 | CN1258282A Parasiticidal pyrazoles |
| 06/28/2000 | CN1258280A Cyanoamidines as cell proliferation inhibitors |
| 06/28/2000 | CN1258279A Cyanoguanidines as cell proliferation inhibitors |
| 06/28/2000 | CN1258278A Cyanoguanidines as cell proliferation inhibitors |
| 06/28/2000 | CN1258277A Cyanoguanidines as cell proliferation inhibitors |
| 06/28/2000 | CN1258276A Cyanoguanidines as cell proliferation inhibitors |
| 06/28/2000 | CN1258229A Betaine product, method for its manufacture, and its use |
| 06/28/2000 | CN1258219A Benzocycloheptathiophene compounds |
| 06/28/2000 | CN1258218A Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof |
| 06/28/2000 | CN1258217A Pharmaceutical formulation of omeprazole |
| 06/28/2000 | CN1258191A Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 06/28/2000 | CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 06/28/2000 | CN1257860A Process for synthesizing ketoibuprofen |
| 06/28/2000 | CN1257726A Medicine for treating ophthalmopathy |
| 06/28/2000 | CN1257711A Liquid medicine for treating beriberi |
| 06/28/2000 | CN1257707A Health-care medicine for improving vitality of old people and its prescription |
| 06/28/2000 | CN1257706A Application of butyl phthalide in preparing medicines curing thrombosis and thrombocyte coagulation |
| 06/28/2000 | CN1053911C Closed-large ring lactone and closed-azalactones compounds and their preparation process |
| 06/28/2000 | CN1053907C Process for manufacture of tricyclic compound |
| 06/28/2000 | CN1053906C Phthalocyanine Zn complex, its producing process, and use for producing anticancer medicine |
| 06/28/2000 | CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them |
| 06/28/2000 | CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same |
| 06/28/2000 | CN1053898C Process for preparation of 2-{4-[4-(4-loro-1-pyrazolyl) butyl]-1-piperazinyl} pyrimidine |
| 06/28/2000 | CN1053897C Crystal modification of pyrimidinyl-phenylamine, its preparing method and use, and composition contg. same |
| 06/28/2000 | CN1053895C Substd. sulfonic acid amide, preparation process and pharmaceutical composition of same |
| 06/28/2000 | CN1053886C Naphthyl compounds, intermediates and their preparing method and use |
| 06/28/2000 | CN1053810C Compound capsule for fever release, pain stop and anti-inflammation |
| 06/28/2000 | CN1053809C Compound preparation for throat diseases |
| 06/28/2000 | CN1053808C Nivadipine controlled-release agent |
| 06/28/2000 | CN1053807C Vitamin E drop |
| 06/28/2000 | CA2293088A1 Method and composition for masking taste and odor from fish oil |
| 06/27/2000 | US6080878 Method of preparing 16-dehydro vitamin D compounds |
| 06/27/2000 | US6080877 Taxanes |
| 06/27/2000 | US6080875 Method for preparing 2-thienylethylamine derivatives |
| 06/27/2000 | US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| 06/27/2000 | US6080871 Sulfonamides and sulfamides as H3 receptor antagonists |
| 06/27/2000 | US6080869 Chemical reduction process; forming dopamine da2 receptor agonists and beta2 adrenoreceptor agonists for treating obstructive airways diseases |
| 06/27/2000 | US6080866 A chemical intermediates for endothelin receptor antagonists |
| 06/27/2000 | US6080851 Ribozymes with linked anchor sequences |
| 06/27/2000 | US6080841 Human induced tumor protein |
| 06/27/2000 | US6080791 A viricide to kill the enveloped virus comprises a 1,4-dihydroxy 2-alkyl benzene or 1,4-dihydroxy 3-alkyl benzene |
| 06/27/2000 | US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction |
| 06/27/2000 | US6080788 Composition for improvement of cellular nutrition and mitochondrial energetics |
| 06/27/2000 | US6080787 Methods for reducing the incidence of necrotizing enterocolitis |
| 06/27/2000 | US6080786 Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine choline tartrate |
| 06/27/2000 | US6080785 Reacting a alkylnedi-primary amine compound with a protective group such as trifluoroacetyl or benzyl group reagent to form an intermediate, reacting the intermediate with haloacetic tert-bytyl ester to form ester groups, deprotecting |
| 06/27/2000 | US6080783 Applying the zinc gluconate and a carrier in preferred ratio to the nose epithelial membrane and maintaining the medicine in contact with nose membrane for atleast 10 minutes to cure common cold in human |
| 06/27/2000 | US6080782 Cyclohexyl dihydrobenzofuranes |
| 06/27/2000 | US6080781 Dissolving tetralone or benzopyranone compounds and a benzaldehyde compound in organic solvent, refluxing with heating under acidic condition and purifying the reactio product; useful for treating hormone dependent disease |
| 06/27/2000 | US6080780 Use of nitroflavonoids for the treatment of anxiety |
| 06/27/2000 | US6080779 Administering to a vertebrate animal suffering from bone loss an effective amount of an aromatic or heterocyclic hydroxy ester compound, estrogen and derivatives and bisphosphonate or derivatives to enhance the bone formation |
| 06/27/2000 | US6080778 Methods for decreasing beta amyloid protein |
| 06/27/2000 | US6080776 Used as a microbiocide for crop protection |
| 06/27/2000 | US6080774 Substituted biphenylsulfonamide endothelin antagonists |
| 06/27/2000 | US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders |
| 06/27/2000 | US6080769 Imidazolidin-4-one derivatives useful as anticancer agents |
| 06/27/2000 | US6080768 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 06/27/2000 | US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/27/2000 | US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| 06/27/2000 | US6080765 Pharmaceutical composition |
| 06/27/2000 | US6080764 Superoxide radical inhibitor |
| 06/27/2000 | US6080763 Inhibit the release of inflammatory cytokines, e.g., tumor necrosis factor and interleukin-1; useful to treat chronic inflammatory disease; autoimmune diseases, e.g. rheumatoid arthritis, osteoporosis; pyrazolylureas |
| 06/27/2000 | US6080762 Having the patient inhale an aerosolized amount of raloxifene (hydrochloride) through the patient's mouth or nose into the lungs; aerosols; postmenopausal syndrome; osteoporosis |
| 06/27/2000 | US6080761 Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 06/27/2000 | US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis |
| 06/27/2000 | US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer |
| 06/27/2000 | US6080755 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives |